MRP ₹164.99
(Inclusive of all Taxes)
₹24.8 Cashback (15%)
Extra 15% Off with Bank Offers
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Composition :
TERBINAFINE-250MG
Manufacturer/Marketer :
Skinska Pharmaceutica Pvt Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Have a query?
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Terbiska-250 Tablet:
Co-administration of Pimozide and Terbiska-250 Tablet can increase the blood levels of pimozide and the risk of side effects.
How to manage the interaction:
Co-administration of pimozide and Terbiska-250 Tablet is not recommended as it can lead to an interaction, but it can be taken if your doctor advises. However, if you experience any symptoms like muscle spasms or movements that you can't stop or control, such as lip smacking, chewing, puckering, frowning or scowling, tongue thrusting, teeth clenching, jaw twitching, blinking, eye-rolling, shaking or jerking of arms and legs, tremor, jitteriness, restlessness, pacing, and foot tapping, dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations, contact your doctor immediately. Do not discontinue any medications without consulting your doctor.
Co-administration of Pimozide and Terbiska-250 Tablet can increase the blood levels of pimozide and the risk of side effects.
How to manage the interaction:
Co-administration of pimozide and Terbiska-250 Tablet is not recommended as it can lead to an interaction, but it can be taken if your doctor advises. However, if you experience any symptoms like muscle spasms or movements that you can't stop or control, such as lip smacking, chewing, puckering, frowning or scowling, tongue thrusting, teeth clenching, jaw twitching, blinking, eye-rolling, shaking or jerking of arms and legs, tremor, jitteriness, restlessness, pacing, and foot tapping, dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations, contact your doctor immediately. Do not discontinue any medications without consulting your doctor.
Critical
How does the drug interact with Terbiska-250 Tablet:
Co-administration of Thioridazine together with Terbiska-250 Tablet can increase the blood levels of Thioridazine and increase the risk of an irregular heart rhythm.
How to manage the interaction:
Co-administration of Thioridazine and Terbiska-250 Tablet is not recommended as it can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like sudden dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
Co-administration of Thioridazine together with Terbiska-250 Tablet can increase the blood levels of Thioridazine and increase the risk of an irregular heart rhythm.
How to manage the interaction:
Co-administration of Thioridazine and Terbiska-250 Tablet is not recommended as it can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like sudden dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
Severe
How does the drug interact with Terbiska-250 Tablet:
Co-administration of Leflunomide and Terbiska-250 Tablet can increase the risk or severity of liver problems.
How to manage the interaction:
Although there is an interaction between leflunomide and Terbiska-250 Tablet, they can be taken together if prescribed by a doctor. However, if you experience fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, less desire to eat, fatigue, nausea, vomiting, abdominal pain, or yellowing of the skin or eyes, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Leflunomide and Terbiska-250 Tablet can increase the risk or severity of liver problems.
How to manage the interaction:
Although there is an interaction between leflunomide and Terbiska-250 Tablet, they can be taken together if prescribed by a doctor. However, if you experience fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, less desire to eat, fatigue, nausea, vomiting, abdominal pain, or yellowing of the skin or eyes, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Terbiska-250 Tablet:
Co-administration of Vortioxetine and Terbiska-250 Tablet can increase the blood levels and side effects of vortioxetine like serotonin syndrome (A condition in which a chemical called serotonin builds up in your body)
How to manage the interaction:
Co-administration of Vortioxetine and Terbiska-250 Tablet can lead to an interaction, but it can be taken if a doctor advises. However, if you experience any symptoms like confusion, hallucination, seizure, increased heart rate, fever, excessive sweating, shivering or shaking, blurred vision, muscle spasm or stiffness, tremor, incoordination, stomach cramps, nausea, vomiting, diarrhea, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Vortioxetine and Terbiska-250 Tablet can increase the blood levels and side effects of vortioxetine like serotonin syndrome (A condition in which a chemical called serotonin builds up in your body)
How to manage the interaction:
Co-administration of Vortioxetine and Terbiska-250 Tablet can lead to an interaction, but it can be taken if a doctor advises. However, if you experience any symptoms like confusion, hallucination, seizure, increased heart rate, fever, excessive sweating, shivering or shaking, blurred vision, muscle spasm or stiffness, tremor, incoordination, stomach cramps, nausea, vomiting, diarrhea, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
TerbinafinePitolisant
Severe
How does the drug interact with Terbiska-250 Tablet:
Co-administration of Pitolisant and Terbiska-250 Tablet can increase the risk of an irregular heart rhythm and increase the blood levels of Pitolisant.
How to manage the interaction:
Co-administration of Pitolisant and Terbiska-250 Tablet can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like headache, insomnia, nausea, anxiety, increased heart rate, hallucinations, abdominal pain, and muscle pain, diarrhea or vomiting, contact your doctor immediately. Do not discontinue any medications without consulting your doctor.
Co-administration of Pitolisant and Terbiska-250 Tablet can increase the risk of an irregular heart rhythm and increase the blood levels of Pitolisant.
How to manage the interaction:
Co-administration of Pitolisant and Terbiska-250 Tablet can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like headache, insomnia, nausea, anxiety, increased heart rate, hallucinations, abdominal pain, and muscle pain, diarrhea or vomiting, contact your doctor immediately. Do not discontinue any medications without consulting your doctor.
TerbinafineLomitapide
Severe
How does the drug interact with Terbiska-250 Tablet:
Co-administration of Lomitapide and Terbiska-250 Tablet can increase the risk or severity of liver problems.
How to manage the interaction:
Co-administration of Lomitapide and Terbiska-250 Tablet can lead to an interaction, but it can be taken if your doctor advises. However, if you experience any symptoms like fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, and/or yellowing of the skin or eyes, contact your doctor immediately. Do not discontinue any medications without consulting your doctor.
Co-administration of Lomitapide and Terbiska-250 Tablet can increase the risk or severity of liver problems.
How to manage the interaction:
Co-administration of Lomitapide and Terbiska-250 Tablet can lead to an interaction, but it can be taken if your doctor advises. However, if you experience any symptoms like fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, and/or yellowing of the skin or eyes, contact your doctor immediately. Do not discontinue any medications without consulting your doctor.
Severe
How does the drug interact with Terbiska-250 Tablet:
Co-administration of Tamoxifen with Terbiska-250 Tablet may reduce the effectiveness of Tamoxifen.
How to manage the interaction:
Although taking Tamoxifen and Terbiska-250 Tablet together can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience any symptoms, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Tamoxifen with Terbiska-250 Tablet may reduce the effectiveness of Tamoxifen.
How to manage the interaction:
Although taking Tamoxifen and Terbiska-250 Tablet together can possibly result in an interaction, it can be taken if your doctor has advised it. However, if you experience any symptoms, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Terbiska-250 Tablet:
Co-administration of Teriflunomide and Terbiska-250 Tablet can increase the risk or severity of liver problems.
How to manage the interaction:
Co-administration of Teriflunomide and Terbiska-250 Tablet can lead to an interaction, but it can be taken if your doctor advises. However, if you experience symptoms like fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, and/or yellowing of the skin or eyes, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
Co-administration of Teriflunomide and Terbiska-250 Tablet can increase the risk or severity of liver problems.
How to manage the interaction:
Co-administration of Teriflunomide and Terbiska-250 Tablet can lead to an interaction, but it can be taken if your doctor advises. However, if you experience symptoms like fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, abdominal pain, dark-colored urine, light-colored stools, and/or yellowing of the skin or eyes, contact your doctor immediately. Do not discontinue any medications without first consulting your doctor.
How does the drug interact with Terbiska-250 Tablet:
Co-administration of Dextromethorphan and Terbiska-250 Tablet may increase the side effects of Dextromethorphan.
How to manage the interaction:
Taking Dextromethorphan and Terbiska-250 Tablet together can possibly result in an interaction, but it can be taken if a doctor has advised it. However, if you experience any symptoms like difficulty breathing, dizziness, drowsiness, anxiety, restless feeling, nervousness, confusion, or diarrhea, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Dextromethorphan and Terbiska-250 Tablet may increase the side effects of Dextromethorphan.
How to manage the interaction:
Taking Dextromethorphan and Terbiska-250 Tablet together can possibly result in an interaction, but it can be taken if a doctor has advised it. However, if you experience any symptoms like difficulty breathing, dizziness, drowsiness, anxiety, restless feeling, nervousness, confusion, or diarrhea, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
TerbinafineEliglustat
Severe
How does the drug interact with Terbiska-250 Tablet:
Coadministration of Terbiska-250 Tablet with Eliglustat can increase the levels and side effects of Eliglustat.
How to manage the interaction:
Although there is a possible interaction between Terbiska-250 Tablet and Eliglustat, you can take these medicines together if prescribed by your doctor. However, if you experience nausea, upset stomach, abdominal pain, gas/bloating, diarrhea, headache, back pain, arm/leg pain, dizziness, or weakness, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Coadministration of Terbiska-250 Tablet with Eliglustat can increase the levels and side effects of Eliglustat.
How to manage the interaction:
Although there is a possible interaction between Terbiska-250 Tablet and Eliglustat, you can take these medicines together if prescribed by your doctor. However, if you experience nausea, upset stomach, abdominal pain, gas/bloating, diarrhea, headache, back pain, arm/leg pain, dizziness, or weakness, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Alcohol
Not applicable
-
Pregnancy
Not applicable
-
Breast Feeding
Not applicable
-
Driving
Not applicable
-
Liver
Consult your doctor
If your child has a history of liver diseases/conditions, please inform your doctor.
Kidney
Consult your doctor
If your child has a history of kidney diseases/conditions, please inform your doctor.
Children
Caution
Terbiska-250 Tablet is safe to use for children aged 4 years and above if prescribed by the doctor.
Heart
Please consult your doctor before giving Terbiska-250 Tablet to your child. Your doctor will prescribe Terbiska-250 Tablet if the benefits outweigh the risks.
Geriatrics
Not applicable
Terbiska-250 Tablet is for paediatric patients only.
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
